佳礼资讯网

 找回密码
 注册

ADVERTISEMENT

楼主: 留下眼镜

【CCM 2879 交流专区】马化工

  [复制链接]
发表于 2-11-2013 02:35 AM | 显示全部楼层
马化工重组业务

财经新闻 财经  2013-11-03 11:22
(吉隆坡2日讯)马化工(CCM,2879,主板工业产品股)建议进行内部业务重组,来达成优化成本和合理化业务组合的策略。

马化工向马交所报备,董事部已批准该内部重组活动建议,即通过独资子公司———CCM Usaha Kimia(M)私人有限公司,分别向集团收购CCMInnovative Solutions私人有限的99.07%股权,及CCM Chemicals私人有限公司的80%股权。

通过上述预期在明年次季完成的重组活动,该集团将创造一个化学业务旗舰公司,并由单一董事部来管理。

“这预期可加强和精简企业的监管、政策和流程,并确保集团可良好管控该风险。”

此外,马化工在周五(1日)宣布,旗下涉及制药业务的子公司———CCM Duopharma Biotech,将与韩国PanGen生化科技公司,进行第3期的贫血药物临床实验。

“一旦这个在11月开始的临床实验成功,集团将拥有在大马、新加坡和汶莱,行销与分销该药物的权利,预计每年总值5000万令吉。”

上述临床实验将涉及800万令吉的成本。[南洋网财经]

CHEMICAL COMPANY OF MALAYSIA BERHAD

Type
Announcement
Subject
OTHERS
Description
Proposed Internal Restructuring
1.0    BACKGROUND
We are pleased to announce that the Board of Directors of the Chemical Company of Malaysia Berhad (“CCM” or “the Company”) has approved the Proposed Internal

Restructuring exercise on the acquisition by CCM Usaha Kimia (M) Sdn Bhd (“UKSB”) of 99.07%  equity interest in CCM Innovative Solutions Sdn Bhd (“CCMIS”)  and 80% equity interest in CCM Chemicals Sdn Bhd (“CCMC”) from the Company (“Proposed Internal Restructuring”).


2.0    PARTIES TO THE PROPOSED INTERNAL RESTRUCTURING     
2.1    The Company is an investment holding and management company with subsidiaries engaged in the manufacturing and marketing of fertilizers, chemicals and pharmaceuticals products and services and is listed on Bursa Malaysia.

2.2    UKSB is a private limited company by shares and is incorporated in Malaysia.  The principal business of UKSB is to trade as an agent and in its own right in chemicals and other commodities.  UKSB is a wholly owned subsidiary of the Company.

2.3    CCMC is a private company limited by shares and is incorporated in Malaysia.  The principal business of CCMC is manufacturing and marketing of chlor-alkali and coagulant products and marketing of industrial and specialty chemicals. CCMC is an 80% subsidiary company of the Company.

2.4    CCMIS is a private company limited by shares and is incorporated in Malaysia.  The principal business of CCMIS is manufacturing and selling of industrial cleaner  and hydrogel coating products.  CCMIS is a wholly owned subsidiary of the Company.

3.0    DETAILS OF THE PROPOSED INTERNAL RESTRUCTURING
3.1    Under the proposed internal restructuring, the Company shall sell its shares held in CCMC and CCMIS to UKSB with all rights attached or accruing to them and free  from all encumbrances  and subject to and upon the terms and conditions of the Share Sale Agreements referred to in paragraph 3.2 below. The following total purchase consideration was arrived at after taking into account the costs of investment of the Company in CCMIS and CCMC on a “willing buyer and willing seller" basis and would be satisfied via the issuance of new UKSB shares to the Company as follows:

                Name       (%)CCM’s Direct          CCM’s Shareholding[1]    Vendor    Purchaser        Total Consideration        Total Number of  New Shares[1]
                                     Equity Interest                                                                                                (RM)                       to be Issued by UKSB
               CCMC               80.00                         16,000,000                  CCM          UKSB               46,571,000                          11,066,868
               CCMIS              99.07[2]                     127,754,848                  CCM          UKSB              121,754,847                          28,933,132
               Total                                                                                                                                168,325,847                         40,000,000
   
                Note:
                1.    Comprising ordinary shares of par value RM1 each.
                2.    Remaining 0.93% currently held by UKSB.

3.2    In relation to the proposed internal restructuring, the following Agreements were executed on 1 November 2013:
a)     Share Sale Agreement between the Company and UKSB in respect of the acquisition of the entire 80% equity interest of CCMC.
b)     Share Sale Agreement between the Company and UKSB in respect of the acquisition of 99.07%  equity interest in CCMIS.

4.0    RATIONALE FOR THE PROPOSED INTERNAL RESTRUCTURING
4.1    The Proposed Internal Restructuring is part of CCM Group’s continuous performance enhancement programme, with all three business divisions implementing various operational initiatives to consolidate their positions, which include cost optimization and business portfolio rationalization strategies. This is done together with other various strategic initiatives to establish a solid foundation for future growth.
     
4.2    The Proposed Internal Restructuring will create a Chemicals Division flagship company which will be under the purview of a single board. This is expected to enhance and streamline the corporate governance practices and policies and procedures as well as ensure that risks are better managed throughout the CCM Group.

5.0    EFFECTS OF THE PROPOSED INTERNAL RESTRUCTURING
5.1    The Proposed Internal Restructuring will not have any material effect on the share capital, shareholding structure, earnings per share, net assets per share and gearing of the Company for the financial year ending 31 December 2013.

6.0    APPROVALS REQUIRED
6.1    The Proposed Internal Restructuring is subject to consents/approvals and/or waivers being obtained from all the relevant third parties, if necessary, under any  contract or undertaking or instrument to which the Company, CCMC, CCMIS and/or UKSB is a party.

7.0    INTEREST OF DIRECTORS, MAJOR SHAREHOLDERS AND PERSONS CONNECTED
7.1    None of the Directors and/or major shareholders or persons connected to them has any interest, direct or indirect in the Proposed Internal Restructuring.

8.0    EXPECTED TIME OF COMPLETION OF THE PROPOSED INTERNAL RESTRUCTURING
8.1    Barring any unforeseen circumstances, the Proposed Internal Restructuring is expected to be completed in Q2 of 2014.

9.0    DIRECTORS STATEMENT
9.1    Having considered all aspects of the Proposed Internal Restructuring, the Board is of the opinion that the Proposed Internal Restructuring is in the best interest of the Company.

10.0   DOCUMENTS FOR INSPECTION
10.1    The Share Sale Agreements are available for inspection by the shareholders of the Company at the Registered Office of the Company at 13th Floor, Menara PNB,  201-A Jalan Tun Razak, 50400 Kuala Lumpur during normal office hours from Mondays to Fridays (except public holidays) for a period of three (3) months  commencing from the date of this announcement.

This announcement is dated 1 November 2013.

本帖最后由 icy97 于 3-11-2013 07:30 PM 编辑

回复

使用道具 举报


ADVERTISEMENT

发表于 1-12-2013 02:12 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2013
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/09/2013
30/09/2012
30/09/2013
30/09/2012
$$'000
$$'000
$$'000
$$'000
1Revenue
311,472
374,049
995,029
1,135,022
2Profit/(loss) before tax
11,138
14,697
36,247
41,376
3Profit/(loss) for the period
9,708
11,708
27,383
30,106
4Profit/(loss) attributable to ordinary equity holders of the parent
9,121
8,222
17,822
18,007
5Basic earnings/(loss) per share (Subunit)
1.99
2.03
3.89
4.45
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
2.15
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.8300
1.8400

回复

使用道具 举报

发表于 30-12-2013 11:47 PM | 显示全部楼层
icy97 发表于 1-10-2013 03:03 AM
脱售土地给大股东 马化工进账7480万

财经新闻 财经  2013-10-02 11:03

独立顾问: 净收益1256万 马化工7480万卖地适当合理

财经新闻 财经  2014-01-01 11:13
(吉隆坡31日讯)独立顾问指出,马化工(CCM,2879,主板工业产品股)以7480万令吉脱售两块吉隆坡地段予大股东国民投资机构(PNB),是“适当且合理”的。

独立顾问艾芬投资银行指出,根据估价师的评估,有关地段约7300万令吉,意味着马化工的脱售价较之溢价181万令吉或2.48%,预计可获得1256万令吉的净收益。

马化工在9月杪时宣布,脱售两块总面积达18万7034万令吉的永久地段,以及土地上的3个单位双层排屋,予国民投资机构。

国民投资机构在马化工持股71.35%。

艾芬投资银行表示,脱售计划将让马化工以高于市价的价格释放产业价值,未来也不再需要更多的维护成本和费用,符合公司致力改善营运效率和表现的目标。

据了解,国民投资机构将再发展有关土地,估价师根据市场低档公寓的叫价,推测该土地发展总值料达2亿1601万令吉。[南洋网财经]

Subject
PART A

PROPOSED DISPOSAL BY CHEMICAL COMPANY OF MALAYSIA BERHAD ("CCM") OF 2 CONTIGUOUS PARCELS OF FREEHOLD LAND TOGETHER WITH 3 UNITS OF DOUBLE-STOREY DETACHED HOUSES ERECTED ON GERAN 25607, LOT 17, SEKSYEN 71, BANDAR DAN DAERAH KUALA LUMPUR, WILAYAH PERSEKUTUAN KUALA LUMPUR AND GERAN 14977, LOT 332, SEKSYEN 71, BANDAR KUALA LUMPUR, DAERAH WILAYAH PERSEKUTUAN ("PROPERTIES") TO PERMODALAN NASIONAL BERHAD FOR A TOTAL CASH CONSIDERATION OF RM74,814,000 ("PROPOSED DISPOSAL")

PART B

INDEPENDENT ADVICE LETTER FROM AFFIN INVESTMENT BANK BERHAD TO THE NON-INTERESTED SHAREHOLDERS OF CCM IN RELATION TO THE PROPOSED DISPOSAL AND

NOTICE OF EXTRAORDINARY GENERAL MEETING
Attachments

本帖最后由 icy97 于 1-1-2014 06:44 PM 编辑

回复

使用道具 举报

发表于 3-1-2014 02:41 AM | 显示全部楼层
icy97 发表于 2-11-2013 02:35 AM
马化工重组业务

财经新闻 财经  2013-11-03 11:22

Type
Announcement
Subject
OTHERS
Description
PROPOSED INTERNAL RESTRUCTURING
We refer to our announcement dated 1 November 2013 and wish to advise that all condition precedents as stipulated in the Share Sale Agreements have been met. Therefore, the Internal Restructuring Exercise has been completed on 1 January 2014.

The announcement is dated 2 January 2014.

回复

使用道具 举报

发表于 14-2-2014 01:33 AM | 显示全部楼层
icy97 发表于 1-10-2013 03:03 AM
脱售土地给大股东 马化工进账7480万

财经新闻 财经  2013-10-02 11:03

马化工售地赚1256万

财经新闻 财经  2014-02-14 10:07
(吉隆坡13日讯)马化工(CCM,2879,主板工业产品股)售地给大股东国民投资机构(PNB)完成,赚利1256万令吉。

这两片相连土地位于敦依斯迈路,拥有永久地契,连3间双层房屋,以7491万令吉一并脱售。

马化工董事局在文告中指出,脱售已完成,并把产业移交给国民投资机构。

根据彭博数据,国民投资机构是马化工最大股东,持有71.91%股权。

马化工是在去年9月30日宣布售地,并表示售地所得,会用作偿还债务和营运资本。

截至2012年杪,有关地段的账面价值为6175万令吉。【南洋网财经】

Type
Announcement
Subject
OTHERS
Description
PROPOSED DISPOSAL BY CHEMICAL COMPANY OF MALAYSIA BERHAD (“CCM”) OF 2 CONTIGUOUS PARCELS OF FREEHOLD LAND TOGETHER WITH 3 UNITS OF DOUBLE-STOREY DETACHED HOUSES ERECTED ON GERAN 25607, LOT 17, SEKSYEN 71, BANDAR DAN DAERAH KUALA LUMPUR, WILAYAH PERSEKUTUAN KUALA LUMPUR AND GERAN 14977, LOT 332, SEKSYEN 71, BANDAR KUALA LUMPUR, DAERAH WILAYAH PERSEKUTUAN (“PROPERTIES”) TO PERMODALAN NASIONAL BERHAD (“PNB”) FOR A TOTAL CASH CONSIDERATION OF RM74,814,000 (“PROPOSED DISPOSAL”)
Reference is made to the earlier announcements dated 30 September 2013, 19 December 2013 and 21 January 2014 in relation to the Proposed Disposal.

The Board of Directors of CCM is pleased to announce that the Proposed Disposal has been completed and vacant possession of the Properties has been delivered to PNB.

This announcement is dated 13 February 2014.

本帖最后由 icy97 于 14-2-2014 09:58 PM 编辑

回复

使用道具 举报

发表于 15-2-2014 01:53 AM | 显示全部楼层
收购韩国公司 马化工进军生物仿製药业

财经 2014年2月14日
(吉隆坡14日讯)隨著收购韩国生物科技公司--PanGen Biotech Inc(Pan Gen)的11.6%股权之后,马化工(CCM,2879,主板工业股)將加速投入生物仿製药工业。       

马化工与该韩国公司,于2013年12月26日签署一项购股协议。这项协议让前者拥有在马来西亚、新加坡和汶莱,將PanGen开发的生物仿製药推出市场,將產品商业化的权利。

马化工董事经理阿米鲁费沙旺查希尔说,「这项投资重申了马化工药剂部进军生物科技业,尤其是生物仿製药的承诺,这些生物仿製药皆为专利权已经失效的现有生物药剂產品的演进版本。」

他补充说,「马化工对PanGen並不陌生,因为这家公司原已是红血球生成素生物仿製药的歷史性第三期联合临床实验的其中一个伙伴。红血球生成素生物仿製药是用来为末期肾衰竭病人治疗贫血症。」

东南亚市值80亿

目前已在进行中的这项临床实验,旨在评估以红血球生成素生物仿製药治疗末期肾衰竭病人的贫血症时,这些药物对病人的安全性与效力。

採用相同基因成份製造的生物仿製药,其药性的发挥、安全性与效力与真正生物药剂是一样的。

阿米鲁费沙指出,向来被国际药剂公司所支配的生物仿製药业,预期在亚洲可在2020年之前取得12%的综合平均增长率,在东南亚的市值则可达到80亿令吉。

马化工在PanGen拥有的股权,让旗下药剂部得以凭著这项策略关係去接触这家韩国公司所推出的生物仿製药管道。全球仅有几家创业生物科技公司拥有PanGen所具备的专门知识、优良记录和相同基因的细胞產品系列。

上述最新发展也將使马化工致力於將生物仿製药商业化时,爭取建立高增值伙伴关係,同时避免投资在非常昂贵的临床实验和长时间的开发期后,才能將產品推出市场。

此外,阿米鲁费沙说,「这项收购行动有利於本公司在未来展开任何生物科技產品业务时,获得科技转移的支援,加速药剂部人力资本在独特与高值生物仿製药產品方面的知识与技术发展。」【东方网财经】
回复

使用道具 举报

Follow Us
发表于 28-2-2014 03:34 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31/12/2013
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/12/2013
31/12/2012
31/12/2013
31/12/2012
$$'000
$$'000
$$'000
$$'000
1Revenue
293,537
379,008
1,288,566
1,514,030
2Profit/(loss) before tax
-15,567
30,506
20,680
71,882
3Profit/(loss) for the period
-15,893
29,913
11,490
54,019
4Profit/(loss) attributable to ordinary equity holders of the parent
-17,675
17,161
5,780
32,291
5Basic earnings/(loss) per share (Subunit)
-3.76
4.67
0.14
9.11
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.7700
1.8400

回复

使用道具 举报

发表于 28-5-2014 05:05 AM | 显示全部楼层
馬化工首季淨利滑14%

企業財經27 May 2014 23:15
(吉隆坡27日訊)馬化工(CCM,2879,主要板工業)截至3月底首季淨利下滑13.8%,至377萬令吉;營業額跌5%至2億7377萬令吉。

另外,馬化工董事經理阿米儒菲薩爾在股東大會后指出,公司前景挑戰,因此會專注加強業務營利能力,極力擴展旗下醫藥、化學和肥料業務,包括在各項業務實施卓越營運和最佳管理實踐,加強區域內地位。

此外,馬化工有意專注在小農網絡,協助提高肥料業務貢獻額。相較其他大租戶,這項業務相對更具穩定性。

化學業務方面,該公司將專注在健康衛生和食品及醫藥領域,加強新產品組合。馬化工亦計劃以自家標籤,向市場推出具持續性賺幅的增值產品。

“受棕油庫存量下滑貢獻,今年原棕油價格料有所改善。”

阿米儒菲薩爾指馬化工肥料業務,將持續專注在合理化成本和卓越營運,並在下個需求更高的施肥季節改善賺幅。【中国报财经】
回复

使用道具 举报


ADVERTISEMENT

发表于 29-5-2014 01:32 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31/03/2014
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/03/2014
31/03/2013
31/03/2014
31/03/2013
$$'000
$$'000
$$'000
$$'000
1Revenue
273,769
288,486
273,769
288,486
2Profit/(loss) before tax
8,737
9,428
8,737
9,428
3Profit/(loss) for the period
6,352
7,106
6,352
7,106
4Profit/(loss) attributable to ordinary equity holders of the parent
3,772
4,376
3,772
4,376
5Basic earnings/(loss) per share (Subunit)
0.82
0.96
0.82
0.96
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.7900
1.7700

回复

使用道具 举报

发表于 31-5-2014 02:02 AM | 显示全部楼层
减轻工业循环影响 马化工拟扩药剂部

二零一四年五月二十八日 晚上七时九分
(吉隆坡28日讯)为减轻集团在工业循环中所受的影响,马化工有限公司(CCM,2879,工业产品组)将继续扩充其药剂部门,锐意达到一个更稳定的产品综合。

继截至2013年12月31日止财政年第4季蒙受1768万令吉净亏损后,该集团将依赖其药剂部门,因该部门录得了34%的税前盈利增长。

马化工透露,其药剂部门的较佳表现是拜提供处方药剂予政府和私人界,以及出口的提升销售所赐。

也从事制造肥料与化学产品的马化工,于2013年第4财季转亏,比较一年前获得净盈利1716万令吉。其收益则按年从3亿7900万令吉滑落22.55%至2亿9354万令吉。

在2013财政年全年,净盈利由2012财政年的3229万令吉急缩82%至578万令吉。收益则降低14.89至12亿9000万令吉,比较之前达15亿1000万令吉。

马化工表示,财务业绩的倒退,主要是因为其肥料与化学产品部门的较低收益和盈利利润,同时于2006年收购的肺炎链球菌疫苗行销权的1580万令吉减值。

“2013下半年原料价格不稳定,尤其是钾肥,导致肥料需求滑落,而氯碱产品偏低平均价格,也加剧了马化工肥料与化学部门的挑战市场环境。”

不过,其集团董事经理阿米鲁表示,针对改善其药剂业务经营所采取的努力已经获得成果。

“药剂产品的需求预料将保持相当稳定,这个部门的前景仍然乐观,因它强化在本地和区域市场的地位。”

他补充:“我们将继续策略性专注于扩大产品优势领域,如肿瘤科、生物治疗和疫苗,同时提升产品线和客户产品。”

阿米鲁指出,原棕油价格的展望预料将在今年回扬,主要受到未来数月预测降低棕油囤货的推动。

“马化工的肥料部门将继续专注于成本优化和营运卓越,以迎合未来成熟季节较高的需求。”【光华日报财经】
回复

使用道具 举报

发表于 28-6-2014 04:15 AM | 显示全部楼层
CHEMICAL COMPANY OF MALAYSIA BERHAD

Type
Announcement
Subject
OTHERS
Description
Proposed Internal Restructuring
1.0 BACKGROUND

We are pleased to announce that the Board of Directors of the Chemical Company of Malaysia Berhad (“CCM” or “the Company”) has approved the Proposed Internal Restructuring Exercise involving the disposal of the Company’s 50.1% equity interest in CCM Fertilizers Sdn Bhd and 100% equity interest, in both CCM Agriculture Sdn Bhd and CCM Agriculture (Sabah) Sdn Bhd (collectively referred to as the “Target Companies”) to its wholly-owned subsidiary, CCM Agri-Max Sdn Bhd (“Proposed Internal Restructuring”).

2.0 PARTIES TO THE PROPOSED INTERNAL RESTRUCTURING

2.1 The Company is an investment holding and management company with subsidiaries engaged in the manufacturing and marketing of fertilizers, chemicals and pharmaceuticals products and services and is listed on the Main Board of  Bursa Malaysia Securities Berhad (“Bursa Malaysia”).

2.2 CCM Agri-Max Sdn Bhd (“CCMAM”) is a private company limited by shares and is incorporated in Malaysia. CCMAM is a wholly owned subsidiary of the Company and is principally engaged in the trading of a wide range of fertilizers.

2.3 CCM Fertilizers Sdn Bhd (“CCMF”) is a private company limited by shares and is incorporated in Malaysia. CCMF is principally engaged in manufacturing and marketing of a wide range of fertilizers. The Company holds 50.1% of the equity interest in CCMF, whereas the remaining 49.9% is held by Lembaga Tabung Haji.

2.4 CCM Agriculture Sdn Bhd (“CCMA”) is a private company limited by shares and is incorporated in Malaysia. CCMA is a wholly owned subsidiary of the Company and is principally engaged in the manufacturing and marketing of fertilizers.

2.5
CCM Agriculture (Sabah) Sdn Bhd (“CCMAS”) is a private company limited by shares and is incorporated in Malaysia. CCMAS is a wholly owned subsidiary of the Company and is principally engaged in the manufacturing and marketing of fertilizers.

1.0 3.0 3.0 DETAILS OF THE PROPOSED INTERNAL RESTRUCTURING

3.1 Under the proposed internal restructuring, the Company shall dispose its shares held in the Target Companies to CCMAM with all rights attached or accruing to them and free from all encumbrances and subject to and upon the terms and conditions as stipulated in the Share Sale Agreements referred to in paragraph 3.3 below.

3.2
The following total purchase consideration was arrived at after taking into account the costs of investment of the Company in the Target Companies on a willing buyer and willing seller basis and shall be satisfied via the issuance of new CCMAM shares to the Company as follows:-

Name of Target Company
CCM’s Direct Total Equity
(%)
CCM’s Shareholding (no. of shares)
Vendor
Purchaser
Total Consideration (RM)
Total Number of New Shares to be Issued by CCMAM
CCMF
50.1
19,539,000
CCM
CCMAM
34,929,600
12,256,000
CCMA
100.0
2,500,100
CCM
CCMAM
4,755,166
2,500,100
CCMAS
100.0
2,500,100
CCM
CCMAM
2,500,100
2,500,100
Total
42,184,866
17,256,200
3.3 In relation to the proposed internal restructuring, the following Agreements were executed on 27 June 2014:

a) Share Sale Agreement between the Company and CCMAM in respect of the disposal of 50.1% equity interest in CCMF.

b) Share Sale Agreement between the Company and CCMAM in respect of the disposal of 100% equity interest in CCMA.

c) Share Sale Agreement between the Company and CCMAM in respect of the disposal of 100% equity interest in CCMAS.

4.0 RATIONALE FOR THE PROPOSED INTERNAL RESTRUCTURING

4.1 The Proposed Internal Restructuring is part of CCM Group’s continuous performance enhancement programme, with all three business divisions implementing various operational initiatives to consolidate their positions, which include cost optimization and business portfolio rationalization strategies. This is done together with other various strategic initiatives to establish a solid foundation for future growth.

4.2 The Proposed Internal Restructuring will create a Fertilizers Division flagship company which will be under the purview of a single board. This is expected to enhance and streamline the corporate governance practices and policies and procedures as well as ensure that risks are better managed throughout the CCM Group.

5.0 EFFECTS OF THE PROPOSED INTERNAL RESTRUCTURING

The Proposed Internal Restructuring will not have any material effect on the share capital, shareholding structure, earnings per share, net assets per share and gearing of the Company for the financial year ending 31 December 2014.

6.0 APPROVALS REQUIRED

The Proposed Internal Restructuring is subject to consents/ approvals and/or waivers being obtained from all the relevant third parties, if necessary, pursuant to the covenants under any contract or undertaking or instrument to which the Company, CCMAM, CCMF, CCMA and/ or CCMAS are a party.

7.0 INTEREST OF DIRECTORS, MAJOR SHAREHOLDERS AND PERSONS CONNECTED

None of the Directors and/or major shareholders or persons connected to them has any interest, direct or indirect in the Proposed Internal Restructuring.

8.0 EXPECTED TIME OF COMPLETION OF THE PROPOSED INTERNAL RESTRUCTURING

Barring any unforeseen circumstances, the Proposed Internal Restructuring is expected to be completed by the third quarter of 2014.

9.0 DIRECTORS STATEMENT

Having considered all aspects of the Proposed Internal Restructuring, the Board of Directors is of the opinion that the Proposed Internal Restructuring is in the best interest of the Company.

10.0 DOCUMENTS FOR INSPECTION

The Share Sale Agreements of the respective Target Companies are available for inspection by the shareholders of the Company at the Registered Office of the Company at 13th Floor, Menara PNB, 201-A, Jalan Tun Razak, 50400 Kuala Lumpur during normal office hours from Mondays to Fridays (except public holidays) for a period of three (3) months commencing from the date of this announcement.

This announcement is dated 27 June 2014.

回复

使用道具 举报

发表于 17-7-2014 01:20 AM | 显示全部楼层
CHEMICAL COMPANY OF MALAYSIA BERHAD

Type
Announcement
Subject
OTHERS
Description
Islamic Financing Package from Al-Rajhi Banking & Investment Corporation (Malaysia) Berhad
1. INTRODUCTION
The Board of Directors of Chemical Company of Malaysia Berhad (“CCM” or “the Company”) wishes to announce that the Company has entered into an agreement to accept the Islamic Financing Package amounting to USD16,666,000.00 (capped to an equivalent amount of RM50,000,000.00 only) (“the Facility”) from Al-Rajhi Banking & Investment Corporation (Malaysia) Berhad (“Al-Rajhi”), upon the terms and conditions as contained in the Bank’s offer letter.

2. RATIONALE FOR THE FACILITY
The Facility is part of the Group’s financing plan to facilitate its business operations, working capital, business expansion, acquisition of new businesses as well as to allow for a third party utilization by the following companies:
Companies
CCM Direct equity
a)
CCM Chemicals Sdn Bhd
80.0%
b)
CCM Fertilizers Sdn Bhd
51.0%
c)
UPHA Pharmaceutical Manufacturing (M) Sdn Bhd
100.0%
d)
CCM Pharmaceuticals Sdn Bhd
100.0%
e)
CCM Innovative Solutions Sdn Bhd
100.0%
f)
CCM Agriculture Sdn Bhd
100.0%
g)
CCM Agriculture (Sabah) Sdn Bhd
100.0%
3. INFORMATION ON CHEMICAL COMPANY OF MALAYSIA BERHAD
CCM was incorporated in Malaysia on 7 August 1963 under the Companies Ordinance, 1940-1946 under the name of Chemical Company of Malaysia Limited. On 15 April 1966, CCM assumed its present name. It was listed on the Main Board of Bursa Securities on 24 March 1966 and having its registered address at 13th Floor, Menara PNB, 201-A Jalan Tun Razak, 50400 Kuala Lumpur.

CCM is an investment holding and management company with subsidiaries and an associate company engaged in the manufacturing, marketing and/ or supply of fertilizers, chemicals and pharmaceuticals products and services.

The information of the companies to be allowed for the third party utilization of the Facility is as follows:

a) CCM Chemicals Sdn Bhd (“CCMC”)
CCMC was incorporated in Malaysia as a private limited company, under the name of ICI Industrial Chemicals (Malaysia) Sdn Bhd on 12 February 1987 and later assumed its present name on 12 February 1995. CCMC is 80% owned by CCM and is principally engaged in the manufacturing and marketing of chlor-alkali and coagulant products and marketing of industrial and specialty chemicals. The remaining 20% of the paid-up capital of CCMC is held by Lanjut Setia Sdn Bhd (10%) and Permodalan Nasional Berhad (10%).


b) CCM Fertilizers Sdn Bhd (“CCMF”)
CCM Fertilizers Sdn Bhd (“CCMF”) is a private company limited by shares and was incorporated in Malaysia on 4 March 1972 under the name of I.C.I Agriculture (Malaysia)(1972) Sdn Bhd and assumed its present name on 15 December 1994. CCMF is principally engaged in manufacturing and marketing of a wide range of fertilizers. The Company holds 50.1% of the equity interest in CCMF, whereas the remaining 49.9% is held by Lembaga Tabung Haji.


c) UPHA Pharmaceutical Manufacturing (M) Sdn Bhd (“UPHA”)
UPHA was incorporated in Malaysia on 28 December 1979 as a private company limited by shares. UPHA is a wholly owned subsidiary of the Company and is principally engaged in the manufacturing of pharmaceutical products and sales of medicines.


d) CCM Pharmaceuticals Sdn Bhd (“CCMP”)
CCMIP was incorporated in Malaysia on 27 May 1978 under the name of UPHA Corpn. (M) Sdn Bhd and assumed its present name on 13 January 2006. CCMP is a private company limited by shares and is a wholly owned subsidiary of the Company. CCMIP is principally engaged in the marketing and sales of medicine and pharmaceutical products.


e) CCM Innovative Solutions Sdn Bhd (“CCMIS”)
CCMIS is a private company limited by shares and was incorporated in Malaysia on 17 October 1995 under the name of Pacific Medicare Sdn Bhd and later assumed its present name on 20 January 2012. CCMIS is a wholly owned subsidiary of the Company and is principally engaged in the manufacturing and trading of polymers and chemical products.


f) CCM Agriculture Sdn Bhd (“CCMA”)
CCMA (formerly known as Orineum Corporation Sdn Bhd) was incorporated in Malaysia on 12 November 1997 and assumed its present name on 10 June 2005. CCMA is a private company limited by shares and is a wholly owned subsidiary of the Company. CCMA is principally engaged in the manufacturing and marketing of fertilizers


g) CCM Agriculture (Sabah) Sdn Bhd (“CCMAS”)
CCMAS (formerly known as Kibaran Kemas Sdn Bhd) was incorporated in Malaysia, under the name of CCM-KINeSYS Sdn Bhd on 18 July 1995 and later assumed its present name on 7 November 2007. CCMAS is a private company limited by shares and is incorporated in Malaysia. CCMAS is a wholly owned subsidiary of the Company and is principally engaged in the manufacturing and marketing of fertilizers.
  
4. FINANCIAL EFFECT OF THE FACILITY
(a) Share Capital
The Facility will not have any effect on the share capital of the Company and the shareholding of the substantial shareholders of the Company.

(b) Net Assets
The Facility will not have any material effect on the net assets of the CCM Group for the financial year ending 31 December 2014.

(c) Earnings
The Facility will not have any material effect on the earnings of the CCM Group for the financial year ending 31 December 2014.

(d) Utilisation of Proceeds
There will be no utilisation of proceeds arising from the acceptance of the Facility.


5. INTERESTS OF DIRECTORS, MAJOR SHAREHOLDERS AND PERSONS CONNECTED
None of the Directors and/or substantial shareholders of CCM and persons connected have any interest, direct or indirect, in the Facility.
  
6. DIRECTORS’ RECOMMENDATION
The Board, after careful deliberation, is of the opinion that acceptance of the Facility is in the best interest of the Company and CCM Group.
  
7. APPROVAL REQUIRED
No approval from the relevant regulatory authority is required for the acceptance of the Facility from Al-Rajhi.
  
8. DOCUMENTS FOR INSPECTION
The relevant agreements in relation to the Facility are available for inspection at the Registered Office of the Company at 13th Floor, Menara PNB, 201-A Jalan Tun Razak, 50400 Kuala Lumpur during normal office hours for a period of one month from the date of this announcement.


This announcement is dated 16 July 2014

回复

使用道具 举报

发表于 22-7-2014 03:11 AM | 显示全部楼层
CHEMICAL COMPANY OF MALAYSIA BERHAD

Type
Announcement
Subject
OTHERS
Description
Third Party Utilisation of the Islamic Financing Package Facility from Al-Rajhi Banking & Investment Corporation (Malaysia) Berhad
1. INTRODUCTION
The Board of Directors of Chemical Company of Malaysia Berhad (“CCM” or “the Company”) wishes to announce that the Company has entered into an agreement with Al-Rajhi Banking & Investment Corporation (Malaysia) Berhad (“Al-Rajhi”), to allow for third party utilization of the Islamic Financing Package Facility (“the Facility”) to its subsidiary, CCM Chemicals Sdn Bhd (“CCMC”), upon the terms and conditions as contained in the Bank’s offer letter.

2. INFORMATION ON CHEMICAL COMPANY OF MALAYSIA BERHAD
CCM was incorporated in Malaysia on 7 August 1963 under the Companies Ordinance, 1940-1946 under the name of Chemical Company of Malaysia Limited. On 15 April 1966, CCM assumed its present name. It was listed on the Main Board of Bursa Securities on 24 March 1966 and having its registered address at 13th Floor, Menara PNB, 201-A Jalan Tun Razak, 50400 Kuala Lumpur.

CCM is an investment holding and management company with subsidiaries and an associate company engaged in the manufacturing, marketing and/ or supply of fertilizers, chemicals and pharmaceuticals products and services.


3.  INFORMATION ON CCM CHEMICALS SDN BHD (“CCMC”)
CCMC was incorporated in Malaysia as a private limited company, under the name of ICI Industrial Chemicals (Malaysia) Sdn Bhd on 12 February 1987 and later assumed its present name on 12 February 1995. CCMC is 80% owned by CCM and is principally engaged in the manufacturing and marketing of chlor-alkali and coagulant products and marketing of industrial and specialty chemicals. The remaining 20% of the paid-up capital of CCMC is held by Lanjut Setia Sdn Bhd (10%) and Permodalan Nasional Berhad (10%).
  
4.         4.    RATIONALE FOR THE THIRD PARTY UTILISATION
CCMC will be drawing down RM10.0 million of the Facility as part of its third party utilization which had been pre-approved under the terms offered by Al-Rajhi to facilitate the funding of its capital expenditure requirements.

5. FINANCIAL EFFECT OF THE FACILITY

(a) Share Capital
The Facility will not have any effect on the share capital of the Company and the shareholding of the substantial shareholders of the Company.

(b) Net Assets
The Facility will not have any material effect on the net assets of the CCM Group for the financial year ending 31 December 2014.

(c) Earnings
The Facility will not have any material effect on the earnings of the CCM Group for the financial year ending 31 December 2014.

(d) Utilisation of Proceeds
There will be no utilisation of proceeds arising from the acceptance of the Facility.


6. INTERESTS OF DIRECTORS, MAJOR SHAREHOLDERS AND PERSONS CONNECTED
None of the Directors and/or substantial shareholders of CCM and persons connected have any interest, direct or indirect, in the Facility.


7. DIRECTORS’ RECOMMENDATION
The Board, after careful deliberation, is of the opinion that acceptance of the Facility is in the best interest of the Company and CCM Group.
  
8. APPROVAL REQUIRED
No approval from the relevant regulatory authority is required for the acceptance of the Facility from Al-Rajhi.
  
9. DOCUMENTS FOR INSPECTION
The relevant agreements in relation to the Facility are available for inspection at the Registered Office of the Company at 13th Floor, Menara PNB, 201-A Jalan Tun Razak, 50400 Kuala Lumpur during normal office hours for a period of one month from the date of this announcement.


This announcement is dated 21 July 2014

http://www.bursamalaysia.com/market/listed-companies/company-announcements/1689533
Attachments

回复

使用道具 举报

发表于 30-8-2014 11:03 PM | 显示全部楼层
马化工人事变动 次季净利挫51%

财经新闻 财经  2014-08-30 11:13
(吉隆坡29日讯)马化工(CCM,2879,主板工业产品股)董事经理阿米鲁费沙宣布请辞,公司另委任伦纳德阿礼夫出任代总执行长一职。

文告显示,现年44岁的阿米鲁费沙另谋高就,辞去原有职务,并在10月1日生效。

在伦敦取得经济科学学士学位的阿米鲁费沙在加入马化工前,曾就职国民投资机构、毕马威(KPMG)和马银行投行等,负责投资银行、企业金融、并购等金融工作,拥有丰富行内经验。

另外,董事局通过了委任伦纳德阿礼夫为代总执行长的建议,并将在阿米鲁费沙离职的同一天生效。

目前,伦纳德阿礼夫是马化工药剂业务的董事,也是旗下马化工药业(CCMDBIO,7148,主板消费产品股)总执行长。

此外,由于化学品和肥料业务表现疲弱,马化工截至6月30日次季净利按年大跌50.9%,写212万令吉。

营业额则挫21.3%,报3亿1110万令吉。

上半年净利减少32.3%,达589万令吉;营业额萎缩14.4%,报5亿8487万令吉。

化学品业务税前盈利跌25.5%,达360万令吉。而肥料业务则是从去年同期的550万令吉净利,转为蒙亏280万令吉。

该公司称,本财年业绩表现料持续面临挑战。【南洋网财经】

SUMMARY OF KEY FINANCIAL INFORMATION
30/06/2014
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/06/2014
30/06/2013
30/06/2014
30/06/2013
$$'000
$$'000
$$'000
$$'000
1Revenue
311,101
395,071
584,870
683,557
2Profit/(loss) before tax
3,995
15,681
12,732
25,109
3Profit/(loss) for the period
3,571
10,569
9,923
17,675
4Profit/(loss) attributable to ordinary equity holders of the parent
2,122
4,325
5,894
8,701
5Basic earnings/(loss) per share (Subunit)
0.46
0.95
1.29
1.90
6Proposed/Declared dividend per share (Subunit)
0.00
0.00
0.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.7900
1.7700

本帖最后由 icy97 于 2-9-2014 02:44 AM 编辑

回复

使用道具 举报

发表于 2-9-2014 02:13 AM | 显示全部楼层
Date of change
01/10/2014
Name
Amirul Feisal bin Wan Zahir
Age
44
Nationality
Malaysian
Designation
Managing Director
Directorate
Executive
Type of change
Resignation
Reason
To pursue career progression
Details of any disagreement that he/she has with the Board of Directors
No
Whether there are any matters that need to be brought to the attention of the shareholders
No
Qualifications
1. Bachelor of Science Economics (Accounting and Finance), London School of Economic, University of London
2. Fellow of the Institute of Chartered Accountants, England and Wales
Working experience and occupation
Before joining Chemical Company of Malaysia Berhad, Encik Amirul Feisal was the Executive Vice President for Special Projects in Permodalan Nasional Berhad. Encik Amirul Feisal started his career in KPMG plc in the Audit Division based in London and left as an Assistant Manager to Schroders Investment Banking in Kuala Lumpur in 1997. He remained at Schroders (later acquired by Salomon Smith Barney and subsequently renamed Citigroup Global Markets) until 2004. During that period Encik Amirul Feisal worked in various departments within the Investment Banking Division including the Project Finance and Privatisation Department, Corporate Finance Group, Mergers & Acquisition Group and the Industrial / Large Cap Group based in Kuala Lumpur, Singapore and Hong Kong. In 2004, Encik Amirul Feisal joined BinaFikir Sdn Bhd, a Malaysian-based boutique advisory firm as a shareholder and Executive Director. Before taking up his current position in September this year, Encik Amirul Feisal was Managing Director, Head Investment Banking for Maybank Investment Bank Bhd from 2008.
Directorship of public companies (if any)
CCM Duopharma Biotech Berhad

回复

使用道具 举报

发表于 26-9-2014 03:22 AM | 显示全部楼层
Type
Announcement
Subject
OTHERS
Description
PT CCM INDONESIA APPEAL TO THE TAX COURT OF INDONESIA
1. INTRODUCTION
The Board of Directors of Chemical Company of Malaysia Berhad (“CCM” or “the Company”) wishes to announce that PT CCM Indonesia (“PTCCMI”), a subsidiary of CCM, has on 23 September 2014, submitted several appeals to the Indonesian Tax Court against the objection decisions of the Director General of Tax (“DGT”) on several tax adjustments/ corrections made by the tax auditor totaling IDR36.1 billion (or equivalent to RM9.7 million) in aggregate.

2. BACKGROUND INFORMATION OF THE APPEAL TO THE TAX COURT OF INDONESIA
For Year Assessment (“YA”) 2011, PTCCMI has requested for tax refund based on its computation of its corporate tax due to its loss position. A request for tax refund in Indonesia will trigger a tax audit due to the requirement for the DGT to decide on a refund request within 12 months from the refund request.


Consequently, a tax audit was conducted by the Indonesian tax auditor which had resulted to various tax adjustments being made by the tax auditor. Based on the tax auditor’s assessments, the additional taxes to be paid arising from the tax adjustments wereIDR36.1 billion (equivalent to RM9.7 million). PTCCMI has submitted objections to the tax adjustments with supporting documents as well as confirmation from banks etc. but was rejected by the DGT.


PTCCMI has appealed to the Tax Court in Indonesia against the DGT’s objection decisions. An Indonesia tax consultancy firm has been appointed by PTCCMI to act on behalf of PTCCMI in the appeal.
3. INFORMATION ON CHEMICAL COMPANY OF MALAYSIA BERHAD
CCM was incorporated in Malaysia on 7 August 1963 under the Companies Ordinance, 1940-1946 under the name of Chemical Company of Malaysia Limited. On 15 April 1966, CCM assumed its present name. It was listed on the Main Board of Bursa Securities on 24 March 1966 and having its registered address at 13th Floor, Menara PNB, 201-A Jalan Tun Razak, 50400 Kuala Lumpur.

CCM is an investment holding and management company with subsidiaries and an associate company engaged in the manufacturing, marketing and/ or supply of fertilizers, chemicals and pharmaceuticals products and services.
  
4. INFORMATION ON PT CCM INDONESIA
PTCCMI was incorporated in Indonesia on 9 September 2002.  CCM Chemicals Sdn Bhd directly holds 99.67% of the shares of PT CCMI whereas the remaining 0.33% is directly held by CCM Watercare Sdn Bhd, a wholly-owned subsidiary of CCM Chemicals Sdn Bhd. CCM has an effective equity interest of 80% in PTCCMI. PTCCMI is principally engaged in the marketing of chemicals.
  
5. INFORMATION ON CCM CHEMICALS SDN BHD
CCM Chemicals Sdn Bhd (“CCMC”) was incorporated in Malaysia as a private limited company, under the name of ICI Industrial Chemicals (Malaysia) Sdn Bhd on 12 February 1987 and later assumed its present name on 12 February 1995.


CCMC is 80% owned by CCM Usaha Kimia (M) Sdn Bhd, a wholly-owned subsidiary of Chemical Company of Malaysia Berhad, and principally engaged in the manufacture and marketing of chlor-alkali and coagulant products and marketing of industrial and specialty chemicals. The other 20% of the paid-up capital of CCMC is held by Lanjut Setia Sdn Bhd (10%) and Permodalan Nasional Berhad (10%).
  
6. FINANCIAL EFFECT
(a) Share Capital
The appeal will not have any effect on the share capital of the Company and the shareholding of the substantial shareholders of the Company.
(b) Net Assets
The appeal will not have any material effect on the net assets of the CCM Group for the financial year ending 31 December 2014.

(c) Earnings
The appeal by PTCCMI to the Tax Court will not have any material effect on the earnings of the CCM Group for the financial year ending 31 December 2014.
  
7. INTERESTS OF DIRECTORS, MAJOR SHAREHOLDERS AND PERSONS CONNECTED
None of the Directors and/or substantial shareholders of CCM and persons connected with CCM have any interest, direct or indirect, in the appeal to the Tax Court of Indonesia.

8. DIRECTORS’ RECOMMENDATION
The Board, after careful deliberation, is of the opinion that the appeal was in best interest of the Company and CCM Group.

9. DOCUMENTS FOR INSPECTION
The relevant documents in relation to the appeals to the Tax Court of Indonesia are available for inspection at the Registered Office of the Company at 13th Floor, Menara PNB, 201-A Jalan Tun Razak, 50400 Kuala Lumpur during normal office hours for a period of one month from the date of this announcement.


This announcement is dated 25 September 2014.

回复

使用道具 举报


ADVERTISEMENT

发表于 26-10-2014 07:54 PM | 显示全部楼层
朝聖基金局成 增持馬化工成主要股東
財經26 Oct 2014 15:49
http://www.chinapress.com.my/node/572056

(吉隆坡26日訊)朝聖基金局(Lembaga Tabung Haji)在過去5個交易日內,不斷增持馬化工(CCM,2879,主要板工業)股權至5.03%,成為主要股東。

馬化工向馬證交所報備,朝聖基金局在16日收購馬化工50萬股后,就增持股權至5.01%,相等于2293萬5700股,成為主要股東。

之后朝聖基金局續在4個交易日內增持馬化工股票,介于2萬3000股至11萬5300股,使股權增至5.03%。

Notice of Interest Sub. S-hldr (29A)
Particulars of Substantial Securities Holder
Name
LEMBAGA TABUNG HAJI
Address
201, JALAN TUN RAZAK,
PETI SURAT NO. 11025,
50732 KUALA LUMPUR.
NRIC/Passport No/Company No.
ACT 5351995
Nationality/Country of incorporation
MALAYSIA (GOVERNMENT AGENCY)
Descriptions (Class & nominal value)
ORDINARY SHARES OF RM1.00 EACH
Name & address of registered holder
LEMBAGA TABUNG HAJI
201, JALAN TUN RAZAK,
PETI SURAT NO. 11025,
50732 KUALA LUMPUR.
Date interest acquired & no of securities acquired
Currency
Malaysian Ringgit (MYR)
Date interest acquired
16/10/2014
No of securities
500,000
Circumstances by reason of which Securities Holder has interest
PURCHASE OF SHARES
Nature of interest
DIRECT INTEREST
Price Transacted ($$)
0.000
Total no of securities after change
Direct (units)
22,935,700
Direct (%)
5.01
Indirect/deemed interest (units)
0
Indirect/deemed interest (%)
0
Date of notice
20/10/2014


Type of transactionDate of change
No of securities
Price Transacted (RM)
Acquired17/10/2014
73,600


Circumstances by reason of which change has occurred
PURCHASE OF SHARES
Nature of interest
DIRECT
Direct (units)
22,935,700
Direct (%)
5.01
Indirect/deemed interest (units)

Indirect/deemed interest (%)
Total no of securities after change
23,009,300
Date of notice
17/10/2014


Type of transactionDate of change
No of securities
Price Transacted (RM)
Acquired20/10/2014
23,000

Acquired21/10/2014
37,000

Acquired23/10/2014
115,300


Circumstances by reason of which change has occurred
PURCHASE OF SHARES
Nature of interest
DIRECT
Direct (units)
23,009,300
Direct (%)
5.03
Indirect/deemed interest (units)

Indirect/deemed interest (%)
Total no of securities after change
23,184,600
Date of notice
23/10/2014
本帖最后由 icy97 于 28-10-2014 05:18 AM 编辑

回复

使用道具 举报

发表于 26-10-2014 09:23 PM | 显示全部楼层
APULA 发表于 26-10-2014 07:54 PM
朝聖基金局成 增持馬化工成主要股東

 (吉隆坡26日訊)朝聖基金局(Lembaga Tabung Haji)在過去5個交易 ...

过去一直都保持在1.10
不知道增持了之后会不会影响股价。。。
回复

使用道具 举报

发表于 20-11-2014 03:22 AM | 显示全部楼层
icy97 发表于 28-6-2014 04:15 AM
3.3 In relation to the proposed internal restructuring, the following Agreements were executed on  ...

Type
Announcement
Subject
OTHERS
Description
PROPOSED INTERNAL RESTRUCTURING
We refer to our announcement dated 27 June 2014 and wish to advise that all condition precedents as stipulated in the Share Sale Agreements have been met. Therefore, the Internal Restructuring exercise has been completed on 19 November 2014.

This announcement is dated 19 November 2014.

回复

使用道具 举报

发表于 30-11-2014 05:59 AM | 显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2014
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/09/2014
30/09/2013
30/09/2014
30/09/2013
$$'000
$$'000
$$'000
$$'000
1Revenue
263,667
311,472
848,537
995,029
2Profit/(loss) before tax
492
11,138
13,224
36,247
3Profit/(loss) for the period
121
9,708
10,044
27,383
4Profit/(loss) attributable to ordinary equity holders of the parent
-2,280
9,121
3,614
17,822
5Basic earnings/(loss) per share (Subunit)
-0.50
1.99
0.79
3.89
6Proposed/Declared dividend per share (Subunit)
2.50
0.00
2.50
2.15


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
1.8100
1.7700

回复

使用道具 举报

您需要登录后才可以回帖 登录 | 注册

本版积分规则

 

ADVERTISEMENT



ADVERTISEMENT



ADVERTISEMENT

ADVERTISEMENT


版权所有 © 1996-2023 Cari Internet Sdn Bhd (483575-W)|IPSERVERONE 提供云主机|广告刊登|关于我们|私隐权|免控|投诉|联络|脸书|佳礼资讯网

GMT+8, 29-3-2024 04:01 PM , Processed in 0.086101 second(s), 22 queries , Gzip On.

Powered by Discuz! X3.4

Copyright © 2001-2021, Tencent Cloud.

快速回复 返回顶部 返回列表